SYP and Alzheimer disease: In this report, we describe the clinical and pathological features of a patient in a clinically early stage of AD-ANCL with all the pathological cellular changes found in terminal AD-ANCL cases, but with minimal or no apparent reduction in CSPα or synaptophysin in the neuropil.